ADMA Biologics Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
ADMA Biologics (ADMA) Reports Q2 Loss of $0.35/Share
August 10, 2018 7:10 AM EDTADMA Biologics (NASDAQ: ADMA) reported Q2 EPS of ($0.35), versus ($0.55) reported last year. Revenue for the quarter came in at $4.7 million, versus $3.4 million reported last year.
For earnings history and earnings-related data on ADMA Biologics (ADMA) click here.
... More